Comparative Pharmacology
Head-to-head clinical analysis: CIPRO HC versus SATRIC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CIPRO HC versus SATRIC.
CIPRO HC vs SATRIC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ciprofloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, preventing DNA replication and transcription; hydrocortisone suppresses inflammation via glucocorticoid receptor activation.
SATRIC is a combination of sulfathiazole, sulfacetamide, and sulfabenzamide, which are sulfonamide antibiotics. They competitively inhibit dihydropteroate synthase, blocking folate synthesis in susceptible bacteria.
Instill 3 drops into the affected ear(s) twice daily (morning and evening) for 7 days.
No standard dosing information available for SATRIC.
None Documented
None Documented
Ciprofloxacin: 4-6 hours (prolonged to 6-9 hours in elderly or renal impairment). Hydrocortisone: 1-2 hours.
3-5 hours in healthy adults; prolonged to 6-8 hours in renal impairment (CrCl < 30 mL/min)
Ciprofloxacin: ~50-70% excreted renally as unchanged drug, ~15% as metabolites; ~20-30% eliminated via biliary/fecal route. Hydrocortisone: metabolized hepatically, renal excretion of metabolites.
Renal: 70% unchanged; fecal: 20%; biliary: 10%
Category C
Category C
Antibiotic/Corticosteroid Combination (Otic)
Antiprotozoal, Antibiotic